Placenta‐ versus bone‐marrow‐derived mesenchymal cells for the repair of segmental bone defects in a rabbit model

• Published in: The FEBS journal Vol. 279; no. 13; pp. 2455 - 2465
• Main Authors: Fan, Zhao‐Xin, Lu, Yao, Deng, Li, Li, Xiu‐Qun, Zhi, Wei, Li‐Ling, Jesse, Yang, Zhi‐Ming, Xie, Hui‐Qi
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.07.2012
• Subjects: Alkaline Phosphatase - metabolism; Animals; Biomedical materials; bone defect; Bone marrow; Bone Marrow Cells - cytology; Bone Regeneration; Cell Differentiation; Cells, Cultured; Coculture Techniques; Collagen Type I - metabolism; Female; Femur - abnormalities; Immunoenzyme Techniques; Immunohistochemistry; mesenchymal stem cells; Mesenchymal Stromal Cells - cytology; Osteogenesis - physiology; placenta; Placenta - cytology; Pregnancy; Rabbits; Stem cells; Tissue Engineering; Wound Healing
• ISSN: 1742-464X; 1742-4658; 1742-4658
• DOI: 10.1111/j.1742-4658.2012.08625.x

Tissue‐engineered bones (TEBs) constructed with bone‐marrow‐derived mesenchymal stem cells (BMSCs) seeded on biomaterial scaffolds have achieved good results for bone defect repair in both animal experiments and clinical trials. This has been limited, however, by the source and quantity of BMSCs. We here explored TEBs constructed by placenta‐derived mesenchymal stem cells (PMSCs) and compared their effect for the repair of critical‐sized segmental osteoperiosteal defects with TEBs constructed with BMSCs. PMSCs were isolated from rabbit placenta by gradient centrifugation and in vitro monolayer culturing, and BMSCs were isolated from the hindlimb bone marrow of newborn rabbit. Primary cultured PMSCs and BMSCs were uniformly in a spindle shape. Immunocytochemistry indicated that both types of cells are positive for CD44 and CD105, and negative for CD34 and CD40L, confirming that they are mesenchymal stem cells. BrdU‐labeled PMSCs and BMSCs were respectively co‐cultured with bio‐derived bone materials to construct TEBs in vitro. Critical‐sized segmental osteoperiosteal defects of radii were created in 24 rabbits by surgery. The defects were repaired with TEBs constructed with PMSCs and BMSCs. The results showed that TEBs constructed by both PMSCs and BMSCs could repair the osteoperiosteal defects in a ‘multipoint’ manner. Measurement of radiography, histology, immunohistochemistry, alkaline phosphatase activity, osteocalcin assaying and biomechanical properties have found no significant difference between the two groups at 2, 4, 8 and 12 weeks after the transplantation (P > 0.05). Taken together, our results indicate that PMSCs have similar biological characteristics and osteogenic capacity to BMSCs and can be used as a new source of seeding cells for TEBs. Tissue engineered bones (TEBs) constructed with placenta‐derived mesenchymal stem cells (PMSCs) and bone marrow‐derived mesenchymal stem cells (BMSCs) were used for repairing critical‐sized segmental osteoperiosteal defects in a rabbit model. In vitro and in vivo studies suggested that PMSCs have similar biological characteristics and osteogenic capacity with BMSCs, and may provide a new source of seeding cells for TEBs.